Kaye Edward M. Md - Net Worth and Insider Trading

Kaye Edward M. Md Net Worth

The estimated net worth of Kaye Edward M. Md is at least $8 Million dollars as of 2024-04-19. Kaye Edward M. Md is the Director of Sarepta Therapeutics Inc and owns about 52,471 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $6 Million. Kaye Edward M. Md is the Director of Cytokinetics Inc and owns about 12,576 shares of Cytokinetics Inc (CYTK) stock worth over $849,509. Kaye Edward M. Md is also the CEO of Stoke Therapeutics Inc and owns about 69,350 shares of Stoke Therapeutics Inc (STOK) stock worth over $835,668. Details can be seen in Kaye Edward M. Md's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kaye Edward M. Md has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).

Transaction Summary of Kaye Edward M. Md

To

Kaye Edward M. Md Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kaye Edward M. Md owns 4 companies in total, including Cytokinetics Inc (CYTK) , Avidity Biosciences Inc (RNA) , and Stoke Therapeutics Inc (STOK) among others .

Click here to see the complete history of Kaye Edward M. Md’s form 4 insider trades.

Insider Ownership Summary of Kaye Edward M. Md

Ticker Comapny Transaction Date Type of Owner
CYTK Cytokinetics Inc 2022-08-05 director
RNA Avidity Biosciences Inc 2020-06-11 director
STOK Stoke Therapeutics Inc 2024-03-19 director & CEO
SRPT Sarepta Therapeutics Inc 2017-07-20 Sr VP & Chief Medical Officer

Kaye Edward M. Md Latest Holdings Summary

Kaye Edward M. Md currently owns a total of 3 stocks. Among these stocks, Kaye Edward M. Md owns 52,471 shares of Sarepta Therapeutics Inc (SRPT) as of July 20, 2017, with a value of $6 Million and a weighting of 78.26%. Kaye Edward M. Md owns 12,576 shares of Cytokinetics Inc (CYTK) as of August 5, 2022, with a value of $849,509 and a weighting of 10.96%. Kaye Edward M. Md also owns 69,350 shares of Stoke Therapeutics Inc (STOK) as of March 19, 2024, with a value of $835,668 and a weighting of 10.78%.

Latest Holdings of Kaye Edward M. Md

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2017-07-20 52,471 115.62 6,066,697
CYTK Cytokinetics Inc 2022-08-05 12,576 67.55 849,509
STOK Stoke Therapeutics Inc 2024-03-19 69,350 12.05 835,668

Holding Weightings of Kaye Edward M. Md


Kaye Edward M. Md Form 4 Trading Tracker

According to the SEC Form 4 filings, Kaye Edward M. Md has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 10,000 shares on July 20, 2017, which brought Kaye Edward M. Md around $410,000.

According to the SEC Form 4 filings, Kaye Edward M. Md has made a total of 3 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cytokinetics Inc is the sale of 11,428 shares on August 5, 2022, which brought Kaye Edward M. Md around $571,400.

According to the SEC Form 4 filings, Kaye Edward M. Md has made a total of 4 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 11,150 shares on March 19, 2024, which brought Kaye Edward M. Md around $68,015.

Insider Trading History of Kaye Edward M. Md

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kaye Edward M. Md Trading Performance

GuruFocus tracks the stock performance after each of Kaye Edward M. Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kaye Edward M. Md is 88.06%. GuruFocus also compares Kaye Edward M. Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kaye Edward M. Md within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kaye Edward M. Md's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kaye Edward M. Md

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.37 88.06 160.65 -4.53 53.31 66.74
Relative Return to S&P 500(%) -0.3 87.16 166.2 2.9 47.2 57.5

Kaye Edward M. Md Ownership Network

Ownership Network List of Kaye Edward M. Md

No Data

Ownership Network Relation of Kaye Edward M. Md


Kaye Edward M. Md Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

Kaye Edward M. Md is the director of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, Kaye Edward M. Md made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 322,500 shares made by Robert I Blum , a net sale of 135,675 shares made by Fady Ibraham Malik , and a net sale of 16,624 shares made by John T Henderson .

In summary, during the past 3 months, insiders sold 82,710 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 82,710 shares. During the past 18 months, 522,157 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 522,157 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

Kaye Edward M. Md Mailing Address

Above is the net worth, insider trading, and ownership report for Kaye Edward M. Md. You might contact Kaye Edward M. Md via mailing address: 3450 Monte Villa Parkway, Bothell Wa 98011.

Discussions on Kaye Edward M. Md

No discussions yet.